Stephen V Faraone Selected Research

Stephen V Faraone Research Topics

Disease

220	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 01/2002
34	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
15	Substance-Related Disorders (Drug Abuse) 01/2016 - 01/2003
15	Bipolar Disorder (Manic Depressive Psychosis) 02/2015 - 07/2002
11	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2004
9	Mania (Manias) 01/2022 - 05/2006
6	Antisocial Personality Disorder (Antisocial Personality) 01/2020 - 02/2006
5	Mood Disorders (Mood Disorder) 01/2022 - 01/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 09/2012
4	Neurodevelopmental Disorders 01/2022 - 01/2016
4	Mental Disorders (Mental Disorder) 01/2021 - 06/2004
4	Alcoholism (Alcohol Abuse) 12/2019 - 01/2003
4	Conduct Disorder (Conduct Disorders) 01/2019 - 02/2009
4	Autistic Disorder (Autism) 03/2017 - 01/2012
4	Anxiety Disorders (Anxiety Disorder) 02/2015 - 02/2006
4	Tics (Tic) 02/2006 - 01/2002
3	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 10/2007
3	Autism Spectrum Disorder 01/2020 - 06/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2019 - 07/2012
3	Tobacco Use Disorder (Nicotine Dependence) 01/2016 - 02/2006
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2014 - 03/2006
2	Sleep Wake Disorders 01/2021 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2019
2	Epilepsy (Aura) 01/2021 - 07/2010
2	Oppositional Defiant Disorder 01/2019 - 02/2009
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Panic Disorder (Panic Attack) 12/2014 - 06/2005
2	Genetic Predisposition to Disease (Genetic Predisposition) 08/2014 - 03/2013
2	Overweight 10/2013 - 09/2008
2	Motor Skills Disorders (Motor Skills Disorder) 10/2013 - 03/2012
2	Psychotic Affective Disorders 03/2013 - 01/2004

Drug/Important Bio-Agent (IBA)

38	Methylphenidate (Ritalin)FDA LinkGeneric 03/2022 - 06/2002
28	Pharmaceutical PreparationsIBA 01/2021 - 04/2002
25	Biological ProductsIBA 01/2022 - 06/2003
19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2002
17	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 07/2004
13	Amphetamine (Amfetamine)FDA LinkGeneric 05/2021 - 04/2005
13	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 06/2016 - 01/2002
13	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2004
12	Lisdexamfetamine Dimesylate FDA Link 01/2021 - 06/2008
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2004
9	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2012
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2017 - 02/2005
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 09/2003
7	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2005
7	3' Untranslated Regions (3' UTR)IBA 10/2013 - 04/2007
7	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2013 - 07/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2004
6	SaltsIBA 09/2011 - 04/2005
5	Nicotine FDA Link 01/2016 - 04/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013 - 01/2002
4	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2022 - 05/2006
4	ViloxazineIBA 11/2021 - 01/2021
4	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2002
4	AmphetaminesIBA 01/2018 - 03/2003
4	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 02/2006
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 07/2013 - 08/2005
4	SmokeIBA 09/2012 - 04/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009 - 05/2007
4	EnzymesIBA 06/2007 - 04/2003
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2007 - 03/2003
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 09/2012
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2013
3	4-aminospiroperidolIBA 10/2018 - 12/2007
3	Naltrexone (ReVia)FDA LinkGeneric 03/2018 - 10/2014
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2013
3	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2017 - 04/2014
3	Guanfacine (Tenex)FDA LinkGeneric 02/2015 - 03/2010
3	BenzodiazepinesIBA 02/2015 - 02/2012
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2014 - 11/2008
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2013 - 12/2011
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2013 - 01/2002
3	Monoamine Oxidase (MAO)IBA 10/2012 - 06/2007
3	AdderallIBA 07/2007 - 06/2002
3	Serotonin ReceptorsIBA 07/2006 - 01/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2006 - 03/2002
2	Antimanic AgentsIBA 01/2022 - 08/2011
2	Opioid Analgesics (Opioids)IBA 01/2020 - 10/2014
2	Genetic Markers (Genetic Marker)IBA 01/2019 - 04/2008
2	Cocaine (Cocaine HCl)IBA 01/2019 - 06/2006
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2018 - 01/2018
2	Opiate AlkaloidsIBA 01/2018 - 06/2006
2	TOR Serine-Threonine KinasesIBA 01/2018 - 09/2012
2	Memantine (Namenda)FDA Link 01/2017 - 06/2016
2	Protons (Proton)IBA 04/2016 - 08/2005
2	SodiumIBA 04/2016 - 10/2013
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2016 - 10/2006
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2005
2	RNA (Ribonucleic Acid)IBA 10/2015 - 12/2008
2	alpha-2 Adrenergic ReceptorsIBA 11/2013 - 03/2006
2	Sodium-Hydrogen ExchangersIBA 10/2013 - 01/2012
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2013 - 11/2006
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 02/2012
2	Polychlorinated Biphenyls (PCBs)IBA 12/2011 - 12/2008
2	Antipsychotic Agents (Antipsychotics)IBA 08/2011 - 05/2006
2	Neurofibromin 2 (Merlin)IBA 07/2010 - 10/2008

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
16	Therapeutics 01/2021 - 07/2002
4	Aftercare (After-Treatment) 01/2019 - 10/2005